Reviewed,
UniProtKB/Swiss-Prot P30530 (UFO_HUMAN)
Last modified
June 16, 2009.
Version 103.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Tyrosine-protein kinase receptor UFO EC=2.7.10.1 Alternative name(s): AXL oncogene | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 894 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May function as a signal transducer between specific cell types of mesodermal origin. In case of filovirus infection, seems to function as a cell entry factor. Ref.8 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Subunit structure | Heterodimer and heterotetramer with GAS6. Ref.12 |
| Subcellular location | |
| Tissue specificity | Highly expressed in metastatic colon tumors. Expressed in primary colon tumors. Weakly expressed in normal colon tissue. |
| Involvement in disease | Has transforming potential in patients with chronic myeloproliferative disorder or chronic myelocytic leukemia. |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. AXL/UFO subfamily. Contains 2 fibronectin type-III domains. Contains 2 Ig-like C2-type (immunoglobulin-like) domains. Contains 1 protein kinase domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Proto-oncogene |
| Domain | Immunoglobulin domain Repeat Signal Transmembrane |
| Ligand | ATP-binding Nucleotide-binding |
| Molecular function | Kinase Receptor Transferase Tyrosine-protein kinase |
| PTM | Disulfide bond Glycoprotein Phosphoprotein |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological process | protein amino acid phosphorylation Inferred from electronic annotation. Source: InterPro signal transduction Ref.2Traceable author statement. Source: ProtInc |
| Cellular component | integral to plasma membrane Ref.2 Traceable author statement. Source: ProtInc |
| Molecular function | ATP binding Inferred from electronic annotation. Source: UniProtKB-KW transmembrane receptor protein tyrosine kinase activity Ref.2Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Long (identifier: P30530-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Short (identifier: P30530-2) The sequence of this isoform differs from the canonical sequence as follows: 429-437: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Chain | 26 – 894 | 869 | Tyrosine-protein kinase receptor UFO | PRO_0000024481 | |||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 26 – 451 | 426 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 452 – 472 | 21 | Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 473 – 894 | 422 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 27 – 128 | 102 | Ig-like C2-type 1 | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 139 – 222 | 84 | Ig-like C2-type 2 | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 225 – 332 | 108 | Fibronectin type-III 1 | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 333 – 427 | 95 | Fibronectin type-III 2 | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 536 – 807 | 272 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 542 – 550 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||
| Region | 26 – 92 | 67 | Interaction with SKP1 and GAS6 | ||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 672 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 567 | 1 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 100 | 1 | Phosphoserine | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 702 | 1 | Phosphotyrosine | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 703 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 875 | 1 | Phosphoserine | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 884 | 1 | Phosphoserine | ||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 43 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 157 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 198 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 339 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 345 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 401 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 56 ↔ 117 | By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 160 ↔ 205 | By similarity | |||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 429 – 437 | 9 | Missing in isoform Short. | VSP_005017 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 112 | 1 | T → M | VAR_045596 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 266 | 1 | N → D: dbSNP rs7249222. | VAR_057990 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 295 | 1 | R → W in a lung neuroendocrine carcinoma sample; somatic mutation. | VAR_045597 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 499 | 1 | R → C in a gastric adenocarcinoma sample; somatic mutation. | VAR_041877 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 515 | 1 | S → G | VAR_041878 | |||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 63 | 1 | E → R: Slightly reduced affinity for GAS6. | ||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 66 | 1 | E → R: Reduced affinity for GAS6. | ||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 84 | 1 | T → R: Reduced affinity for GAS6. | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 303 | 1 | T → P in AAB20305. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 303 | 1 | T → P in CAA40338. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 338 | 1 | E → K in AAA61243. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 430 | 1 | Q → E in AAB20305. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 430 | 1 | Q → E in CAA40338. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 639 | 1 | D → G in AAB20305. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 639 | 1 | D → G in CAA40338. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 696 | 1 | K → I Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 764 | 1 | Q → R in AAH32229. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 36 – 39 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 44 – 46 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 52 – 63 | 12 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 68 – 71 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 80 – 87 | 8 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 89 – 91 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 94 – 106 | 13 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 113 – 121 | 9 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 124 – 127 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 131 – 135 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 140 – 143 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 148 – 150 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 156 – 163 | 8 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 177 | 8 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 179 – 183 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 190 – 194 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 201 – 209 | 9 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 212 – 215 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 219 – 223 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Putative tyrosine kinases expressed in K-562 human leukemia cells." Partanen J., Maekelae T.P., Alitalo R., Lehvaeslaiho H., Alitalo K. Proc. Natl. Acad. Sci. U.S.A. 87:8913-8917(1990) [PubMed: 2247464] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT ASP-266. |
| [2] | "AXL, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase." O'Bryan J.P., Frye R.A., Cogswell P.C., Neubauer A., Kitch B., Prokop C., Espinosa R., le Beau M.M., Earp H., Liu E.T. Mol. Cell. Biol. 11:5016-5031(1991) [PubMed: 1656220] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), VARIANT ASP-266. Tissue: Fibroblast. |
| [3] | "A novel putative tyrosine kinase receptor with oncogenic potential." Janssen J.W.G., Schulz A.S., Steenvoorden A.C.M., Schmidberger M., Strehl S., Ambros P., Bartram C.R. Oncogene 6:2113-2120(1991) [PubMed: 1834974] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), VARIANT ASP-266. |
| [4] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed: 15057824] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG), VARIANT ASP-266. |
| [6] | "A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes." Lee S.-T., Strunk K.M., Spritz R.A. Oncogene 8:3403-3410(1993) [PubMed: 8247543] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 674-730. |
| [7] | "Receptor tyrosine kinases expressed in metastatic colon cancer." Craven R.J., Xu L.H., Weiner T.M., Fridell Y.-W., Dent G.A., Srivastava S., Varnum B., Liu E.T., Cance W.G. Int. J. Cancer 60:791-797(1995) [PubMed: 7896447] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 677-730, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Colon tumor. |
| [8] | "Tyro3 family-mediated cell entry of Ebola and Marburg viruses." Shimojima M., Takada A., Ebihara H., Neumann G., Fujioka K., Irimura T., Jones S., Feldmann H., Kawaoka Y. J. Virol. 80:10109-10116(2006) [PubMed: 17005688] [Abstract] Cited for: FUNCTION AS CELL ENTRY FACTOR IN FILOVIRUS INFECTION. |
| [9] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-702 AND TYR-703, MASS SPECTROMETRY. |
| [10] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, MASS SPECTROMETRY. |
| [11] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-875 AND SER-884, MASS SPECTROMETRY. |
| [12] | "Structural basis for Gas6-Axl signalling." Sasaki T., Knyazev P.G., Clout N.J., Cheburkin Y., Goehring W., Ullrich A., Timpl R., Hohenester E. EMBO J. 25:80-87(2006) [PubMed: 16362042] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 33-227 IN COMPLEX WITH GAS6, MUTAGENESIS OF GLU-63; GLU-66 AND THR-84, SUBUNIT. |
| [13] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed: 17344846] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] MET-112; TRP-295; CYS-499 AND GLY-515. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M76125 mRNA. Translation: AAA61243.1. S65125 mRNA. Translation: AAB20305.1. X57019 mRNA. Translation: CAA40338.1. AC011510 Genomic DNA. No translation available. BC032229 mRNA. Translation: AAH32229.1. | |||||||||||||
| IPI | IPI00296992. IPI00397361. | ||||||||||||
| PIR | A41527. | ||||||||||||
| UniGene | Hs.590970 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P30530. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | P30530. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSG00000167601. Homo sapiens. [Contig view] | ||||||||||||
Organism-specific databases | |||||||||||||
| GeneCards | GC19P046416. | ||||||||||||
| HGNC | HGNC:905. AXL. | ||||||||||||
| MIM | 109135. gene. | ||||||||||||
| PharmGKB | PA25197. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P30530. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.10.1. 247. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P30530. | ||||||||||||
| Bgee | P30530. | ||||||||||||
| CleanEx | HS_AXL. | ||||||||||||
| GermOnline | ENSG00000167601. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR015775. Axl_RTKs. IPR008957. Fibronectin_typ-III-like_fold. IPR003961. FN_III. IPR007110. Ig-like. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR013106. Ig_V-set. IPR000719. Prot_kinase_core. IPR017441. Protein_kinase_ATP_BS. IPR001245. Tyr_pkinase. IPR008266. Tyr_pkinase_AS. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.60.40.30. FN_III-like. 1 hit. G3DSA:2.60.40.10. Ig-like_fold. 2 hits. | ||||||||||||
| PANTHER | PTHR23256:SF156. Axl_RTKs. 1 hit. | ||||||||||||
| Pfam | PF00041. fn3. 2 hits. PF07714. Pkinase_Tyr. 1 hit. PF07686. V-set. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00109. TYRKINASE. | ||||||||||||
| ProDom | PD000001. Prot_kinase. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00060. FN3. 2 hits. SM00409. IG. 2 hits. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS50853. FN3. 2 hits. PS50835. IG_LIKE. 2 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | UFO_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P30530 Secondary accession number(s): Q8N5L2, Q9UD27 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| SIMILARITY comments Index of protein domains and families |

Clusters with


